Category: Diagnostic Technologies

Diagnostic Technologies

Illumina Partners Advance Cancer Research with Multiomics Technologies

Studies demonstrate spatial transcriptomics, 5-base sequencing, and proteomics applications in oncology diagnostics and therapeutic development.

Diagnostic Technologies

New Automated Blood Culture System Receives CE Mark for Infection Diagnosis

The BD BACTEC FXI Culture System has received CE marking under EU IVDR, offering automated blood culture diagnostics with a reported 15% faster pathogen detection than previous models, according to clinical study data.

Diagnostic Technologies

Advocate Health to Launch Drone Delivery Network for Lab Specimens

The partnership with Zipline aims to reduce turnaround times for results by transporting samples between hospitals and laboratories.

Anatomic Pathology

Pathologie Friesland Adopts New Digital Pathology Platform for AI Integration

The regional laboratory will use the Concentriq platform to expand diagnostic services and streamline clinical workflows across its network.

Digital Pathology

AidaBREAST Multi-Omic Assay Demonstrates Spatial Proteomics for Clinical Oncology

The assay predicts both locoregional recurrence risk and radiation therapy benefit in early-stage invasive breast cancer.

Clinical Chemistry

Saladax Biomedical and Thermo Fisher Scientific Partner on Global Distribution of Drug Monitoring Assays

The agreement aims to increase the availability of therapeutic drug monitoring tests for psychiatry and oncology patients using existing laboratory equipment.

Flow Cytometry

Biotium’s New Cell Barcoding Kit Allows Up to 15-Sample Multiplexing in a Single Flow Cytometry Tube

The ViaPlex 2-Color Cell Barcoding Kit uses two reactive fluorescent dyes to combine up to 15 distinct cell populations in one tube, reducing reagent use and run time.

Hematology & Serology

Automated Cytomegalovirus PCR Assay Receives IVDR Certification for Transplant Care

The test allows for simultaneous detection of multiple viruses on a sample-to-answer platform designed for immunocompromised patients.

Immunoassay

Clinical Trial to Evaluate Finger-Prick Blood Test for Alzheimer’s Diagnosis

The study will analyze three key proteins to determine if blood-based biomarkers can provide an earlier and more accessible diagnostic method.

Mass Spectrometry

Biognosys and Michael J. Fox Foundation Partner to Develop Parkinson’s Disease Biomarkers

The collaboration focuses on creating sensitive assays for a common genetic risk factor to guide drug development and clinical trials.

Microbiology

Breath Test Using Carbon Isotopes May Quickly Confirm Bacterial Infections

A proof-of-concept study shows that bacteria-metabolized molecules enriched with carbon-13 produce detectable exhaled CO2, enabling rapid infection identification with inexpensive infrared scanners.

Molecular Diagnostics

Foundation Medicine to Acquire SAGA Diagnostics’ Cancer Monitoring Technology

Foundation Medicine will acquire SAGA Diagnostics’ Pathlight MRD platform, expanding its cancer monitoring portfolio. The $595 million deal is expected to close by Q3 2026, with integration supporting treatment selection and recurrence monitoring.

Point-of-Care

Roche Receives FDA Clearance for Point-of-Care Bordetella Test

The cobas liat system delivers PCR results in 15 minutes, detecting and differentiating between three Bordetella pathogens including whooping cough.

Urinalysis & Toxicology

Rapid Urine Test Identifies Effective UTI Antibiotics in Under Six Hours

A rapid urine test identified effective UTI antibiotics in an average of 5.85 hours, matching standard lab accuracy in a University of Reading study published in the Journal of Antimicrobial Chemotherapy.